Le Lézard
Classified in: Health
Subject: PDT

Rockfield Medical Devices Receives OTC Clearance for the Mobility+ Enteral Feeding System


GALWAY, Ireland, May 8, 2024 /PRNewswire/ -- Rockfield Medical Devices Limited, a commercial-stage medical device company focused on developing solutions to transform the mobility and quality of life of tube feeders, today announced U.S. Food and Drug Administration ("FDA") 510(k) Over the Counter Clearance (OTC) of the Mobility+ Enteral Feeding System.

This FDA clearance allows Rockfield Medical Devices to market the Mobility+ Enteral Feeding System for OTC use in the United States. The Company continues to deliver on its mission to transform tube feeders' mobility and quality of life. "We are excited to get OTC clearance which will allow the Company to supply the Mobility+ Enteral Feeding System without a prescription directly to the consumer (D2C) via multiple sales channels. This importantly will allow the Company to supply Mobility+ to a greater number of tube feeders in a more efficient manner in the United States. This OTC clearance combined also with the new CMS reimbursement Code of B4148 for elastomeric feeding pumps will uniquely give users greater and faster access to the Mobility+ positively transforming mobility and Quality of Life of enteral tube feeders. This is a key to what we are about as a Company, and hence our excitement to announce this positive news" said Tomás Thompson CEO of Rockfield Medical Devices.

The Mobility+ Enteral Feeding System is a portable, lightweight, elastomeric, enteral feeding system that delivers liquid nutrition formula to an enteral access device (feeding tube) in users aged two years and over, in clinical or home care settings. The System has three primary components: a food pouch, a filling set and a giving set. The Mobility+ is for single patient use and is intended for use over a 24-hour period.

Market release of Mobility+ OTC is anticipated in Q3 2024 in the United States.

About Rockfield Medical Devices Limited

Rockfield Medical Devices Limited, a company headquartered in Galway, Ireland, is a commercial-stage medical device company focused on developing solutions to transform tube feeders' mobility and quality of life. Rockfield Medical Devices is developing a portfolio of innovative feeding solutions for tube feeders. The company's first product to market is the Mobility+ Enteral Feeding System, which is now cleared by the FDA for OTC use with an Indication of Use to deliver liquid nutrition formula, to an enteral access device (feeding tube) in users aged two years and over. 

For more information on Rockfield Medical Devices visit https://rockfieldmd.com/, follow the company on LinkedIn here: https://www.linkedin.com/company/19017077/"  or email [email protected]

 

SOURCE Rockfield Medical Devices


These press releases may also interest you

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...



News published on and distributed by: